Syndax Pharmaceuticals (NASDAQ:SNDX) 公布其季度每股虧損為$(1.10)，低於分析師普遍預期的$(1.01)，差距為8.91%。 這是比去年同期每股虧損$(1.00)減少了10%。 公司報告季度銷售額為$7.68百萬，低於分析師普遍預期的$85.91百萬，差距為91.06%。
以上內容來自Benzinga Earnings專欄，原文如下：
Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(1.01) by 8.91 percent. This is a 10 percent decrease over losses of $(1.00) per share from the same period last year. The company reported quarterly sales of $7.68 million which missed the analyst consensus estimate of $85.91 million by 91.06 percent.